WHO Experts’ Group To Take A Call On EUL For Covaxin

The Strategic Advisory Group of Experts on Immunization (SAGE) of the World Health Organisation would be meeting in October to make its recommendations on Bharat Biotech’s COVID-19 vaccine Covaxin on Emergency Use Listing.

According to the SAGE draft agenda, Bharat Biotech is expected to give a presentation on the Vaccine’s safety and efficacy data of clinical trials (phase 1-3 trial results and post-marketing) and Risk management plans and other implementation considerations.

Further SAGA is authorised with advising WHO on overall global policies and strategies, ranging from vaccines and technology, research and development, to delivery of immunization and its linkages with other health interventions. The session will thoroughly discuss the clinical data on Covaxin from phase 1, 2, 3 trials and post-marketing studies on safety, immunogenicity, efficacy and effectiveness, besides updates on global, regional and country-level plans for vaccine safety monitoring.

The report further added that Hanna Nohynek, a member of SAGE, will be presenting a draft recommendation for the vaccine and the session will make its recommendations.